Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.210SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.567SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.541SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.189SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.563SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.34SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.258SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.23.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.21.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.42SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.4.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HF.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.31SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HG.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.4.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.9.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XDBSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.16.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.49SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBL.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.18.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GW.5.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.53.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
XDQ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
HV.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HV.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used